Franklin Resources’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Buy |
24,373
+135
| +0.6% | +$2.53K | ﹤0.01% | 2350 |
|
|
2025
Q1 | $436K | Buy |
24,238
+2,429
| +11% | +$43.7K | ﹤0.01% | 2312 |
|
|
2024
Q4 | $367K | Buy |
21,809
+9,043
| +71% | +$152K | ﹤0.01% | 2423 |
|
|
2024
Q3 | $193K | Buy |
+12,766
| New | +$193K | ﹤0.01% | 2638 |
|
|
2024
Q2 | – | Sell |
-7,006
| Closed | -$104K | – | 2945 |
|
|
2024
Q1 | $104K | Hold |
7,006
| – | – | ﹤0.01% | 2695 |
|
|
2023
Q4 | $102K | Hold |
7,006
| – | – | ﹤0.01% | 2459 |
|
|
2023
Q3 | $75.7K | Sell |
7,006
-11,062
| -61% | -$119K | ﹤0.01% | 2479 |
|
|
2023
Q2 | $233K | Buy |
18,068
+12,373
| +217% | +$160K | ﹤0.01% | 2305 |
|
|
2023
Q1 | $75.2K | Sell |
5,695
-379
| -6% | -$5K | ﹤0.01% | 2143 |
|
|
2022
Q4 | $91.1K | Buy |
6,074
+169
| +3% | +$2.54K | ﹤0.01% | 2136 |
|
|
2022
Q3 | $69K | Buy |
5,905
+54
| +0.9% | +$631 | ﹤0.01% | 2160 |
|
|
2022
Q2 | $66K | Sell |
5,851
-2,734
| -32% | -$30.8K | ﹤0.01% | 2206 |
|
|
2022
Q1 | $257K | Buy |
8,585
+419
| +5% | +$12.5K | ﹤0.01% | 2076 |
|
|
2021
Q4 | $216K | Buy |
8,166
+6,768
| +484% | +$179K | ﹤0.01% | 2207 |
|
|
2021
Q3 | $50K | Buy |
1,398
+150
| +12% | +$5.37K | ﹤0.01% | 2376 |
|
|
2021
Q2 | $54K | Buy |
+1,248
| New | +$54K | ﹤0.01% | 1948 |
|